LB Pharmaceuticals Funding: $130M Raised, Series C
LB Pharmaceuticals is a Biotech company based in New York, NY. It has raised $130M in total funding. Latest round: Series C.
LB Pharmaceuticals funding overview
LB Pharmaceuticals is a Biotech company based in New York, NY. LB Pharmaceuticals has raised $130M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C. Investors on record include Deep Track Capital, Pontifax, TCGX, Vida Ventures. 4 distinct backers are named across the disclosed rounds.
LB Pharmaceuticals at a glance
Total raised
$130M
Latest round
Series C
Industry
Biotech
Headquarters
New York, NY
Notable investors
Deep Track Capital, Pontifax, TCGX, Vida Ventures
Frequently asked about LB Pharmaceuticals funding
How much has LB Pharmaceuticals raised?
LB Pharmaceuticals has raised $130M in total disclosed funding across the rounds on record.
Who has invested in LB Pharmaceuticals?
Deep Track Capital, Pontifax, TCGX, Vida Ventures are named among the investors backing LB Pharmaceuticals.
What was the latest LB Pharmaceuticals funding round?
The most recent disclosed round is a Series C.
Where is LB Pharmaceuticals based?
LB Pharmaceuticals is based in New York, NY.
What sector does LB Pharmaceuticals operate in?
LB Pharmaceuticals is tracked under Biotech from New York, NY, with $130M in disclosed funding.
We update the LB Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in New York and their backers are listed below.
